Japan Pirfenidone Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Pirfenidone market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Pirfenidone market. Detailed analysis of key players, along with key growth strategies adopted by Pirfenidone industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • GNI Group

    • Glenmark Pharmaceuticals

    • Genentech (Roche)

    • Koye Pharmaceuticals

    • Wockhardt

    • Beijing Continent

    • Zydus Cadila

    • Shionogi

    • Lupin Ltd

    • Unimed Unihealth

    • MSN Laboratories

    • Cipla

    • Incepta Pharmaceuticals

    By Type:

    • Tablet

    • Capsule

    • Other

    By End-User:

    • Mild Idiopathic Pulmonary Fibrosis

    • Moderate Idiopathic Pulmonary Fibrosis

    • Other

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pirfenidone Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Pirfenidone Market Size and Growth Rate of Tablet from 2014 to 2026

      • 1.3.2 Japan Pirfenidone Market Size and Growth Rate of Capsule from 2014 to 2026

      • 1.3.3 Japan Pirfenidone Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Pirfenidone Market Size and Growth Rate of Mild Idiopathic Pulmonary Fibrosis from 2014 to 2026

      • 1.4.2 Japan Pirfenidone Market Size and Growth Rate of Moderate Idiopathic Pulmonary Fibrosis from 2014 to 2026

      • 1.4.3 Japan Pirfenidone Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pirfenidone Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pirfenidone by Major Types

      • 3.4.1 Market Size and Growth Rate of Tablet

      • 3.4.2 Market Size and Growth Rate of Capsule

      • 3.4.3 Market Size and Growth Rate of Other

    4 Segmentation of Pirfenidone Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pirfenidone by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pirfenidone in Mild Idiopathic Pulmonary Fibrosis

      • 4.4.2 Market Size and Growth Rate of Pirfenidone in Moderate Idiopathic Pulmonary Fibrosis

      • 4.4.3 Market Size and Growth Rate of Pirfenidone in Other

    5 Market Analysis by Regions

    • 5.1 Japan Pirfenidone Production Analysis by Regions

    • 5.2 Japan Pirfenidone Consumption Analysis by Regions

    6 Hokkaido Pirfenidone Landscape Analysis

    • 6.1 Hokkaido Pirfenidone Landscape Analysis by Major Types

    • 6.2 Hokkaido Pirfenidone Landscape Analysis by Major End-Users

    7 Tohoku Pirfenidone Landscape Analysis

    • 7.1 Tohoku Pirfenidone Landscape Analysis by Major Types

    • 7.2 Tohoku Pirfenidone Landscape Analysis by Major End-Users

    8 Kanto Pirfenidone Landscape Analysis

    • 8.1 Kanto Pirfenidone Landscape Analysis by Major Types

    • 8.2 Kanto Pirfenidone Landscape Analysis by Major End-Users

    9 Chubu Pirfenidone Landscape Analysis

    • 9.1 Chubu Pirfenidone Landscape Analysis by Major Types

    • 9.2 Chubu Pirfenidone Landscape Analysis by Major End-Users

    10 Kinki Pirfenidone Landscape Analysis

    • 10.1 Kinki Pirfenidone Landscape Analysis by Major Types

    • 10.2 Kinki Pirfenidone Landscape Analysis by Major End-Users

    11 Chugoku Pirfenidone Landscape Analysis

    • 11.1 Chugoku Pirfenidone Landscape Analysis by Major Types

    • 11.2 Chugoku Pirfenidone Landscape Analysis by Major End-Users

    12 Shikoku Pirfenidone Landscape Analysis

    • 12.1 Shikoku Pirfenidone Landscape Analysis by Major Types

    • 12.2 Shikoku Pirfenidone Landscape Analysis by Major End-Users

    13 Kyushu Pirfenidone Landscape Analysis

    • 13.1 Kyushu Pirfenidone Landscape Analysis by Major Types

    • 13.2 Kyushu Pirfenidone Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 GNI Group

      • 14.1.1 GNI Group Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Glenmark Pharmaceuticals

      • 14.2.1 Glenmark Pharmaceuticals Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Genentech (Roche)

      • 14.3.1 Genentech (Roche) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Koye Pharmaceuticals

      • 14.4.1 Koye Pharmaceuticals Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Wockhardt

      • 14.5.1 Wockhardt Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Beijing Continent

      • 14.6.1 Beijing Continent Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Zydus Cadila

      • 14.7.1 Zydus Cadila Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Shionogi

      • 14.8.1 Shionogi Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Lupin Ltd

      • 14.9.1 Lupin Ltd Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Unimed Unihealth

      • 14.10.1 Unimed Unihealth Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 MSN Laboratories

      • 14.11.1 MSN Laboratories Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Cipla

      • 14.12.1 Cipla Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Incepta Pharmaceuticals

      • 14.13.1 Incepta Pharmaceuticals Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 127 Figures and 161 Tables)

    • Figure Japan Pirfenidone Market Size and Growth Rate of Tablet from 2014 to 2026

    • Figure Japan Pirfenidone Market Size and Growth Rate of Capsule from 2014 to 2026

    • Figure Japan Pirfenidone Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Pirfenidone Market Size and Growth Rate of Mild Idiopathic Pulmonary Fibrosis from 2014 to 2026

    • Figure Japan Pirfenidone Market Size and Growth Rate of Moderate Idiopathic Pulmonary Fibrosis from 2014 to 2026

    • Figure Japan Pirfenidone Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Pirfenidone Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pirfenidone Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pirfenidone

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pirfenidone by Different Types from 2014 to 2026

    • Table Consumption Share of Pirfenidone by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Tablet

    • Figure Market Size and Growth Rate of Capsule

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pirfenidone by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pirfenidone by Different End-Users from 2014 to 2026

    • Figure Japan Pirfenidone Market Size and Growth Rate of Mild Idiopathic Pulmonary Fibrosis from 2014 to 2026

    • Figure Japan Pirfenidone Market Size and Growth Rate of Moderate Idiopathic Pulmonary Fibrosis from 2014 to 2026

    • Figure Japan Pirfenidone Market Size and Growth Rate of Other from 2014 to 2026

    • Table Japan Pirfenidone Production by Regions

    • Table Japan Pirfenidone Production Share by Regions

    • Figure Japan Pirfenidone Production Share by Regions in 2014

    • Figure Japan Pirfenidone Production Share by Regions in 2018

    • Figure Japan Pirfenidone Production Share by Regions in 2026

    • Table Japan Pirfenidone Consumption by Regions

    • Table Japan Pirfenidone Consumption Share by Regions

    • Figure Japan Pirfenidone Consumption Share by Regions in 2014

    • Figure Japan Pirfenidone Consumption Share by Regions in 2018

    • Figure Japan Pirfenidone Consumption Share by Regions in 2026

    • Table Hokkaido Pirfenidone Consumption by Types from 2014 to 2026

    • Table Hokkaido Pirfenidone Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Pirfenidone Consumption Share by Types in 2014

    • Figure Hokkaido Pirfenidone Consumption Share by Types in 2018

    • Figure Hokkaido Pirfenidone Consumption Share by Types in 2026

    • Table Hokkaido Pirfenidone Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Pirfenidone Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Pirfenidone Consumption Share by End-Users in 2014

    • Figure Hokkaido Pirfenidone Consumption Share by End-Users in 2018

    • Figure Hokkaido Pirfenidone Consumption Share by End-Users in 2026

    • Table Tohoku Pirfenidone Consumption by Types from 2014 to 2026

    • Table Tohoku Pirfenidone Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Pirfenidone Consumption Share by Types in 2014

    • Figure Tohoku Pirfenidone Consumption Share by Types in 2018

    • Figure Tohoku Pirfenidone Consumption Share by Types in 2026

    • Table Tohoku Pirfenidone Consumption by End-Users from 2014 to 2026

    • Table Tohoku Pirfenidone Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Pirfenidone Consumption Share by End-Users in 2014

    • Figure Tohoku Pirfenidone Consumption Share by End-Users in 2018

    • Figure Tohoku Pirfenidone Consumption Share by End-Users in 2026

    • Table Kanto Pirfenidone Consumption by Types from 2014 to 2026

    • Table Kanto Pirfenidone Consumption Share by Types from 2014 to 2026

    • Figure Kanto Pirfenidone Consumption Share by Types in 2014

    • Figure Kanto Pirfenidone Consumption Share by Types in 2018

    • Figure Kanto Pirfenidone Consumption Share by Types in 2026

    • Table Kanto Pirfenidone Consumption by End-Users from 2014 to 2026

    • Table Kanto Pirfenidone Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Pirfenidone Consumption Share by End-Users in 2014

    • Figure Kanto Pirfenidone Consumption Share by End-Users in 2018

    • Figure Kanto Pirfenidone Consumption Share by End-Users in 2026

    • Table Chubu Pirfenidone Consumption by Types from 2014 to 2026

    • Table Chubu Pirfenidone Consumption Share by Types from 2014 to 2026

    • Figure Chubu Pirfenidone Consumption Share by Types in 2014

    • Figure Chubu Pirfenidone Consumption Share by Types in 2018

    • Figure Chubu Pirfenidone Consumption Share by Types in 2026

    • Table Chubu Pirfenidone Consumption by End-Users from 2014 to 2026

    • Table Chubu Pirfenidone Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Pirfenidone Consumption Share by End-Users in 2014

    • Figure Chubu Pirfenidone Consumption Share by End-Users in 2018

    • Figure Chubu Pirfenidone Consumption Share by End-Users in 2026

    • Table Kinki Pirfenidone Consumption by Types from 2014 to 2026

    • Table Kinki Pirfenidone Consumption Share by Types from 2014 to 2026

    • Figure Kinki Pirfenidone Consumption Share by Types in 2014

    • Figure Kinki Pirfenidone Consumption Share by Types in 2018

    • Figure Kinki Pirfenidone Consumption Share by Types in 2026

    • Table Kinki Pirfenidone Consumption by End-Users from 2014 to 2026

    • Table Kinki Pirfenidone Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Pirfenidone Consumption Share by End-Users in 2014

    • Figure Kinki Pirfenidone Consumption Share by End-Users in 2018

    • Figure Kinki Pirfenidone Consumption Share by End-Users in 2026

    • Table Chugoku Pirfenidone Consumption by Types from 2014 to 2026

    • Table Chugoku Pirfenidone Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Pirfenidone Consumption Share by Types in 2014

    • Figure Chugoku Pirfenidone Consumption Share by Types in 2018

    • Figure Chugoku Pirfenidone Consumption Share by Types in 2026

    • Table Chugoku Pirfenidone Consumption by End-Users from 2014 to 2026

    • Table Chugoku Pirfenidone Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Pirfenidone Consumption Share by End-Users in 2014

    • Figure Chugoku Pirfenidone Consumption Share by End-Users in 2018

    • Figure Chugoku Pirfenidone Consumption Share by End-Users in 2026

    • Table Shikoku Pirfenidone Consumption by Types from 2014 to 2026

    • Table Shikoku Pirfenidone Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Pirfenidone Consumption Share by Types in 2014

    • Figure Shikoku Pirfenidone Consumption Share by Types in 2018

    • Figure Shikoku Pirfenidone Consumption Share by Types in 2026

    • Table Shikoku Pirfenidone Consumption by End-Users from 2014 to 2026

    • Table Shikoku Pirfenidone Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Pirfenidone Consumption Share by End-Users in 2014

    • Figure Shikoku Pirfenidone Consumption Share by End-Users in 2018

    • Figure Shikoku Pirfenidone Consumption Share by End-Users in 2026

    • Table Kyushu Pirfenidone Consumption by Types from 2014 to 2026

    • Table Kyushu Pirfenidone Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Pirfenidone Consumption Share by Types in 2014

    • Figure Kyushu Pirfenidone Consumption Share by Types in 2018

    • Figure Kyushu Pirfenidone Consumption Share by Types in 2026

    • Table Kyushu Pirfenidone Consumption by End-Users from 2014 to 2026

    • Table Kyushu Pirfenidone Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Pirfenidone Consumption Share by End-Users in 2014

    • Figure Kyushu Pirfenidone Consumption Share by End-Users in 2018

    • Figure Kyushu Pirfenidone Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of GNI Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GNI Group

    • Figure Sales and Growth Rate Analysis of GNI Group

    • Figure Revenue and Market Share Analysis of GNI Group

    • Table Product and Service Introduction of GNI Group

    • Table Company Profile and Development Status of Glenmark Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Glenmark Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Glenmark Pharmaceuticals

    • Table Product and Service Introduction of Glenmark Pharmaceuticals

    • Table Company Profile and Development Status of Genentech (Roche)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche)

    • Figure Sales and Growth Rate Analysis of Genentech (Roche)

    • Figure Revenue and Market Share Analysis of Genentech (Roche)

    • Table Product and Service Introduction of Genentech (Roche)

    • Table Company Profile and Development Status of Koye Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Koye Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Koye Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Koye Pharmaceuticals

    • Table Product and Service Introduction of Koye Pharmaceuticals

    • Table Company Profile and Development Status of Wockhardt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wockhardt

    • Figure Sales and Growth Rate Analysis of Wockhardt

    • Figure Revenue and Market Share Analysis of Wockhardt

    • Table Product and Service Introduction of Wockhardt

    • Table Company Profile and Development Status of Beijing Continent

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beijing Continent

    • Figure Sales and Growth Rate Analysis of Beijing Continent

    • Figure Revenue and Market Share Analysis of Beijing Continent

    • Table Product and Service Introduction of Beijing Continent

    • Table Company Profile and Development Status of Zydus Cadila

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zydus Cadila

    • Figure Sales and Growth Rate Analysis of Zydus Cadila

    • Figure Revenue and Market Share Analysis of Zydus Cadila

    • Table Product and Service Introduction of Zydus Cadila

    • Table Company Profile and Development Status of Shionogi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi

    • Figure Sales and Growth Rate Analysis of Shionogi

    • Figure Revenue and Market Share Analysis of Shionogi

    • Table Product and Service Introduction of Shionogi

    • Table Company Profile and Development Status of Lupin Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin Ltd

    • Figure Sales and Growth Rate Analysis of Lupin Ltd

    • Figure Revenue and Market Share Analysis of Lupin Ltd

    • Table Product and Service Introduction of Lupin Ltd

    • Table Company Profile and Development Status of Unimed Unihealth

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unimed Unihealth

    • Figure Sales and Growth Rate Analysis of Unimed Unihealth

    • Figure Revenue and Market Share Analysis of Unimed Unihealth

    • Table Product and Service Introduction of Unimed Unihealth

    • Table Company Profile and Development Status of MSN Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MSN Laboratories

    • Figure Sales and Growth Rate Analysis of MSN Laboratories

    • Figure Revenue and Market Share Analysis of MSN Laboratories

    • Table Product and Service Introduction of MSN Laboratories

    • Table Company Profile and Development Status of Cipla

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla

    • Figure Sales and Growth Rate Analysis of Cipla

    • Figure Revenue and Market Share Analysis of Cipla

    • Table Product and Service Introduction of Cipla

    • Table Company Profile and Development Status of Incepta Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Incepta Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Incepta Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Incepta Pharmaceuticals

    • Table Product and Service Introduction of Incepta Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.